NEOANGIOGENESIS IS REDUCED IN CHRONIC TENDINOPATHIES OF TYPE 2 DIABETIC PATIENTS

被引:23
作者
Abate, M. [1 ]
Schiavone, C. [2 ]
Salini, V. [3 ]
机构
[1] Univ G dAnnunzio, G dAnnunzio Univ Fdn, Chieti, Italy
[2] Univ G dAnnunzio, Echog Unit, Dept Med & Sci Aging, Chieti, Italy
[3] Univ G dAnnunzio, Dept Med & Sci Aging, Chieti, Italy
关键词
neoangiogenesis; tendinopathy; diabetes; vascular endothelial growth factor; ultrasonography; ENDOTHELIAL GROWTH-FACTOR; GLYCATION END-PRODUCTS; ANGIOGENESIS; PATHOGENESIS; DYSFUNCTION; IMPAIRMENT; FIBROBLAST; TENDONS;
D O I
10.1177/039463201202500322
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In diabetes, the prevalence of tendon degeneration is increased. As neoangiogenesis is impaired in several diabetic complications, the aim of this study is to evaluate the neovessel formation in tendinopathies. Patients aged > 55 years were selected, and divided into two groups: a) type 2 diabetic patients, and b) non-diabetic subjects. In both groups, those with ultrasound features of tendinopathy were included, and intratendinous vascularisation was estimated by means of Power Doppler. Ultrasound features of tendinopathy were observed in 104 diabetic subjects and in 221 controls. Neovascularisation, with higher Power Doppler scores, was found more frequently in controls, while lower Power Doppler scores were prevalent in diabetic subjects. In subjects with diabetes, tendinopathic features are significantly higher than healthy controls, while the prevalence of neovascularization inside tendons is less represented.
引用
收藏
页码:757 / 761
页数:5
相关论文
共 17 条
[1]   LIMITED JOINT MOBILITY IN DIABETES AND AGEING: RECENT ADVANCES IN PATHOGENESIS AND THERAPY [J].
Abate, M. ;
Schiavone, C. ;
Pelotti, P. ;
Salini, V. .
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2010, 23 (04) :997-1003
[2]   Pathogenesis of tendinopathies: inflammation or degeneration? [J].
Abate, Michele ;
Silbernagel, Karin Gravare ;
Siljeholm, Carl ;
Di Iorio, Angelo ;
De Amicis, Daniele ;
Salini, Vincenzo ;
Werner, Suzanne ;
Paganelli, Roberto .
ARTHRITIS RESEARCH & THERAPY, 2009, 11 (03) :235
[3]  
Ahluwalia A, 2010, J PHYSIOL PHARMACOL, V61, P133
[4]  
Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc19-S002, 10.2337/dc12-S064, 10.2337/dc23-S002, 10.2337/dc09-S062, 10.2337/dc18-S002]
[5]   Mechanism of Sustained Release of Vascular Endothelial Growth Factor in Accelerating Experimental Diabetic Healing [J].
Brem, Harold ;
Kodra, Arber ;
Golinko, Michael S. ;
Entero, Hyacinth ;
Stojadinovic, Olivera ;
Wang, Vincent M. ;
Sheahan, Claudia M. ;
Weinberg, Alan D. ;
Woo, Savio L. C. ;
Ehrlich, H. Paul ;
Tomic-Canic, Marjana .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2009, 129 (09) :2275-2287
[6]   Insulin-dependent diabetes impairs the inflammatory response and delays angiogenesis following Achilles tendon injury [J].
Chbinou, N ;
Frenette, J .
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2004, 286 (05) :R952-R957
[7]   Advanced glycation end products induce cell cycle arrest and proinflammatory changes in osteoarthritic fibroblast-like synovial cells [J].
Franke, Sybille ;
Sommer, Manfred ;
Ruester, Christiane ;
Bondeva, Tzvetanka ;
Marticke, Julia ;
Hofmann, Gunther ;
Hein, Gert ;
Wolf, Gunter .
ARTHRITIS RESEARCH & THERAPY, 2009, 11 (05)
[8]  
Grassi W, 2000, ARTHRITIS RHEUM, V43, P969, DOI 10.1002/1529-0131(200005)43:5<969::AID-ANR2>3.0.CO
[9]  
2-4
[10]   Cellular dysfunction in the diabetic fibroblast - Impairment in migration, vascular endothelial growth factor production, and response to hypoxia [J].
Lerman, OZ ;
Galiano, RD ;
Armour, M ;
Levine, JP ;
Gurtner, GC .
AMERICAN JOURNAL OF PATHOLOGY, 2003, 162 (01) :303-312